DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 40 filers reported holding DEPOMED INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,008,000 | +13.3% | 1,200,000 | 0.0% | 0.05% | +15.2% |
Q3 2017 | $890,000 | -16.0% | 1,200,000 | 0.0% | 0.05% | -14.8% |
Q2 2017 | $1,060,000 | -2.4% | 1,200,000 | +20.0% | 0.05% | -49.5% |
Q4 2014 | $1,086,000 | +2.0% | 1,000,000 | 0.0% | 0.11% | -14.4% |
Q3 2014 | $1,065,000 | – | 1,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 8,078,000 | $5,958,000 | 3.38% |
Shaolin Capital Management LLC | 10,167,000 | $7,584,000 | 1.17% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,635,000 | $7,844,000 | 1.14% |
CSS LLC/IL | 3,917,000 | $2,921,000 | 0.19% |
BlueCrest Capital Management Ltd | 3,000,000 | $2,234,000 | 0.15% |
MOORE CAPITAL MANAGEMENT, LP | 4,000,000 | $2,980,000 | 0.12% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,100,000 | $1,564,000,000 | 0.04% |
OAKTREE CAPITAL MANAGEMENT LP | 2,780,000 | $2,077,000 | 0.04% |
Private Harbour Investment Management & Counsel, LLC | 25,000 | $18,000 | 0.02% |
WELLS FARGO & COMPANY/MN | 20,011,000 | $14,808,000 | 0.00% |